Burst antitachycardia pacing (ATP) is higly efficacious for termination of monomorphic ventricular tachycardia (MVT). Since several pacing sequences are usually programmed as a single therapy. optimal programming is presently unknown. In 40 patients (P) with MVT and a 3rd generation AICD, 4 burst ATP were prospectively compared (as afirst single ATP) during followup in a randomized design crossing over every 2–3 months. Burst ATP modes (A to D) were defined by pacing cycle length (PCL, as % of VTCL) and number of beats (No B) (Table). A second ATP zone was programmed in a non selected way in all patientsResults (Table)374 episodes (317 considered MVT) received ATP therapies in 23 patients. RR intervals could be retrieved for MVT-CL analysis...
Anti-tachycardia pacing (ATP) is frequently used to terminate ventricular tachycardia (VT), however ...
Abstract Background Anti‐tachycardia pacing (ATP) delivered from an implantable device is a useful t...
Background: In hypertrophic cardiomyopathy (HCM) patients implanted with an implantable cardioverter...
Burst antitachycardia pacing (ATP) is higly efficacious for termination of monomorphic ventricular t...
The value of testing antitachycardia pacing (ATP) for the termination of ventricular tachycardias (V...
Implantable cardioverter defibrillator (ICD) programming involves several parameters. In recent year...
AbstractObjectives. This study compared the efficacy and safety of two antitachycardia pacing algori...
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/72440/1/j.1540-8159.1993.tb01531.x.pd
BACKGROUND: Antitachycardia pacing (ATP) is routinely used to terminate ventricular tachyarrhythmi...
Ventricular Tachycardia. The objective of this study was to compare prospectively the efficacy of fi...
BACKGROUND Little is known about the ICD performance using enhanced detection algorithms in unselec...
BackgroundAntitachycardia pacing (ATP) is an effective treatment for ventricular tachycardia (VT). W...
BACKGROUND: In Multicenter Automatic Defibrillator Implantation Trial - Reduce Inappropriate Therapy...
Aims: We sought to evaluate the efficacy and safety of different antitachycardia pacing (ATP) sites ...
AbstractObjectivesThis study evaluated the safety and efficacy of atrial pacing therapies for the tr...
Anti-tachycardia pacing (ATP) is frequently used to terminate ventricular tachycardia (VT), however ...
Abstract Background Anti‐tachycardia pacing (ATP) delivered from an implantable device is a useful t...
Background: In hypertrophic cardiomyopathy (HCM) patients implanted with an implantable cardioverter...
Burst antitachycardia pacing (ATP) is higly efficacious for termination of monomorphic ventricular t...
The value of testing antitachycardia pacing (ATP) for the termination of ventricular tachycardias (V...
Implantable cardioverter defibrillator (ICD) programming involves several parameters. In recent year...
AbstractObjectives. This study compared the efficacy and safety of two antitachycardia pacing algori...
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/72440/1/j.1540-8159.1993.tb01531.x.pd
BACKGROUND: Antitachycardia pacing (ATP) is routinely used to terminate ventricular tachyarrhythmi...
Ventricular Tachycardia. The objective of this study was to compare prospectively the efficacy of fi...
BACKGROUND Little is known about the ICD performance using enhanced detection algorithms in unselec...
BackgroundAntitachycardia pacing (ATP) is an effective treatment for ventricular tachycardia (VT). W...
BACKGROUND: In Multicenter Automatic Defibrillator Implantation Trial - Reduce Inappropriate Therapy...
Aims: We sought to evaluate the efficacy and safety of different antitachycardia pacing (ATP) sites ...
AbstractObjectivesThis study evaluated the safety and efficacy of atrial pacing therapies for the tr...
Anti-tachycardia pacing (ATP) is frequently used to terminate ventricular tachycardia (VT), however ...
Abstract Background Anti‐tachycardia pacing (ATP) delivered from an implantable device is a useful t...
Background: In hypertrophic cardiomyopathy (HCM) patients implanted with an implantable cardioverter...